-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Cadrenal Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q1 2022 to Q1 2025.
- Cadrenal Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$4.65M, a 153% decline year-over-year.
- Cadrenal Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$7.36M, a 108% decline from 2023.
- Cadrenal Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$3.53M, a 193% decline from 2022.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)